» Articles » PMID: 21902581

Opportunistic and Other Infections in HIV-infected Children in Latin America Compared to a Similar Cohort in the United States

Overview
Publisher Mary Ann Liebert
Date 2011 Sep 10
PMID 21902581
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Opportunistic and other infections have declined since the introduction of highly active antiretroviral therapy (HAART) in developed countries but few studies have addressed the impact of HAART in HIV-infected children from developing countries. This study examines the prevalence and incidence of opportunistic and other infections in Latin America during the HAART era. Vertically HIV-infected children enrolled in a cohort study between 2002 and 2007 were followed for the occurrence of 29 targeted infections. Cross-sectional and longitudinal analyses were performed to calculate the prevalence of infections before enrollment and the incidence rates of opportunistic and other infections after enrollment. Comparisons were made with data from a U.S. cohort (PACTG 219C). Of the 731 vertically HIV-infected children 568 (78%) had at least one opportunistic or other infection prior to enrollment. The most prevalent infections were bacterial pneumonia, oral candidiasis, varicella, tuberculosis, herpes zoster, and Pneumocystis jiroveci pneumonia. After enrollment, the overall incidence was 23.5 per 100 person-years; the most common infections (per 100 person-years) were bacterial pneumonia (7.8), varicella (3.0), dermatophyte infections (2.9), herpes simplex (2.5), and herpes zoster (1.8). All of these incidence rates were higher than those reported in PACTG 219C. The types and relative distribution of infections among HIV-infected children in Latin America in this study are similar to those seen in the United States but the incidence rates are higher. Further research is necessary to determine the reasons for these higher rates.

Citing Articles

Opportunistic infections among schoolchildren who were on antiretroviral therapy in Ethiopia: a systematic review and meta-analysis.

Birhanu M, Telayneh A, Kassie A, Tegegne E, Jemberie S Front Pediatr. 2024; 12:1255111.

PMID: 39649399 PMC: 11620863. DOI: 10.3389/fped.2024.1255111.


Incidence and predictors of opportunistic infections among HIV-infected children on antiretroviral therapy at public health facilities of Southwest Ethiopia People Regional State, 2023: a multicenter retrospective follow-up study.

Admasu N, Jihad M, Kebede A, Getnet M BMC Pediatr. 2024; 24(1):653.

PMID: 39394104 PMC: 11468083. DOI: 10.1186/s12887-024-05117-y.


Incidence and predictors of common opportunistic infections among children living with HIV at Bahir Dar City, Ethiopia.

Kerebeh G, Kefale D, Chanie E, Moges N, Feleke D, Kassaw A Sci Rep. 2024; 14(1):23403.

PMID: 39379418 PMC: 11461838. DOI: 10.1038/s41598-024-72404-0.


Predictors for the incidence of pneumonia among HIV-infected children on antiretroviral therapy in Amhara Regional State Comprehensive Specialized Hospitals, Ethiopia: a multicenter retrospective follow-up study.

Mekonnen G, Baye F, Kerebeh G, Fekadie M, Kassie Y, Demile T Ital J Pediatr. 2024; 50(1):165.

PMID: 39232814 PMC: 11375993. DOI: 10.1186/s13052-024-01695-w.


Predictors of a high incidence of opportunistic infections among HIV-infected children receiving antiretroviral therapy at Amhara regional state comprehensive specialized hospitals, Ethiopia: A multicenter institution-based retrospective follow-up....

Mekonnen G, Birhane B, Engdaw M, Kindie W, Ayele A, Wondim A Front Pediatr. 2023; 11:1107321.

PMID: 37205221 PMC: 10185808. DOI: 10.3389/fped.2023.1107321.


References
1.
Pena A, Larranaga C, Luchsinger V, Villarroel J, Chavez A, Wu E . [Cytomegalovirus disease in HIV-1 infected Chilean children]. Rev Chilena Infectol. 2008; 24(6):477-84. DOI: /S0716-10182007000600008. View

2.
Mubiana-Mbewe M, Bolton-Moore C, Banda Y, Chintu N, Nalubamba-Phiri M, Giganti M . Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia. Trop Med Int Health. 2009; 14(10):1190-8. PMC: 3897250. DOI: 10.1111/j.1365-3156.2009.02360.x. View

3.
Levin M, Anderson J, Seage 3rd G, Williams P . Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr. 2009; 50(2):182-91. PMC: 2748317. DOI: 10.1097/QAI.0b013e31819550a4. View

4.
Calder D, Qazi S . Evidence behind the WHO guidelines: hospital care for children: what is the aetiology of pneumonia in HIV-infected children in developing countries?. J Trop Pediatr. 2009; 55(4):219-24. DOI: 10.1093/tropej/fmp047. View

5.
Hazra R, Stoszek S, Hance L, Pinto J, Marques H, Peixoto M . Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol. 2008; 38(5):1207-14. PMC: 2767114. DOI: 10.1093/ije/dyn239. View